(Q40285261)

English

Changes in metabolite ratios after treatment with rivastigmine in Alzheimer's disease: a nonrandomised controlled trial with magnetic resonance spectroscopy

scientific article published on January 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Changes in metabolite ratios after treatment with rivastigmine in Alzheimer's disease: a nonrandomised controlled trial with magnetic resonance spectroscopy (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Alzheimer's disease

0 references

author name string

Pedro J Modrego

1

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Miguel A Pina

2

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Nicolás Fayed

3

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Marcos Díaz

4

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

publication date

1 January 2006

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

20

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

867-877

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

describes a project that uses

NMR spectroscopy

1 reference

based on heuristic

inferred from title

https://scigraph.springernature.com/pub.10.2165/00023210-200620100-00006

0 references

Magnetic resonance spectroscopy in AD.

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200620100-00006

21 January 2018

1H MR spectroscopy in common dementias

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200620100-00006

21 January 2018

Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200620100-00006

21 January 2018

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200620100-00006

21 January 2018

Alzheimer disease: quantitative H-1 MR spectroscopic imaging of frontoparietal brain

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200620100-00006

21 January 2018

Selective reduction of N-acetylaspartate in medial temporal and parietal lobes in AD

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200620100-00006

21 January 2018

Alzheimer disease: depiction of increased cerebral myo-inositol with proton MR spectroscopy

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200620100-00006

21 January 2018

Probable Alzheimer disease: diagnosis with proton MR spectroscopy

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200620100-00006

21 January 2018

Brain proton magnetic resonance spectroscopy (1H-MRS) in Alzheimer's disease: changes after treatment with xanomeline, an M1 selective cholinergic agonist

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200620100-00006

21 January 2018

Randomized, Placebo-Controlled Trial of the Effects of Donepezil on Neuronal Markers and Hippocampal Volumes in Alzheimer’s Disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/16999455

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced N-acetylaspartate content in the frontal part of the brain in patients with probable Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/16999455

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16999455

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regional effects of donepezil and rivastigmine on cortical acetylcholinesterase activity in Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/16999455

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/16999455

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo brain concentrations of N-acetyl compounds, creatine, and choline in Alzheimer disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16999455

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Longitudinal PET evaluation of cerebral glucose metabolism in rivastigmine treated patients with mild Alzheimer's disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16999455

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo magnetic resonance spectroscopy of human brain: the biophysical basis of dementia

1 reference

https://pubmed.ncbi.nlm.nih.gov/16999455

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16999455

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The relationship between cognitive impairment and in vivo metabolite ratios in patients with clinical Alzheimer's disease and vascular dementia: a proton magnetic resonance spectroscopy study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16999455

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rivastigmine in Alzheimer disease: efficacy over two years

1 reference

https://pubmed.ncbi.nlm.nih.gov/16999455

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metabolic patterns associated with the clinical response to galantamine therapy: a fludeoxyglucose f 18 positron emission tomographic study

1 reference

https://pubmed.ncbi.nlm.nih.gov/16999455

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Brain proton magnetic resonance spectroscopy in Alzheimer disease: changes after treatment with xanomeline

1 reference

https://pubmed.ncbi.nlm.nih.gov/16999455

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alterations in brain activation during cholinergic enhancement with rivastigmine in Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/16999455

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monitoring disease progression in transgenic mouse models of Alzheimer's disease with proton magnetic resonance spectroscopy

1 reference

https://pubmed.ncbi.nlm.nih.gov/16999455

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Does donepezil treatment slow the progression of hippocampal atrophy in patients with Alzheimer's disease?

1 reference

https://pubmed.ncbi.nlm.nih.gov/16999455

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Brain perfusion follow-up in Alzheimer's patients during treatment with acetylcholinesterase inhibitors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16999455

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cognocitive mini-test (a simple practical test to detect intellectual changes in medical patients)

1 reference

https://pubmed.ncbi.nlm.nih.gov/16999455

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biochemical markers of cognition: a proton MR spectroscopy study of normal human brain

1 reference

https://pubmed.ncbi.nlm.nih.gov/16999455

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Brain proton spectroscopy in dementia: an aid to clinical diagnosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16999455

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation of regional proton magnetic resonance spectroscopic metabolic changes with cognitive deficits in mild Alzheimer disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/16999455

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessing the severity of dementia. Patient and caregiver

1 reference

https://pubmed.ncbi.nlm.nih.gov/16999455

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Degree of inhibition of cortical acetylcholinesterase activity and cognitive effects by donepezil treatment in Alzheimer's disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16999455

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metaanalysis of randomized trials of the efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/16999455

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rivastigmine for Alzheimer's disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16999455

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00023210-200620100-00006

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40285261&oldid=1893449273"